Anticipated Impact of Drug-Eluting Stents on Referral Patterns for Coronary Artery Bypass Graft Surgery: A Population-Based Angiographic Analysis

Powell, Brian D.; Rihal, Charanjit S.; Bell, Malcolm R.; Zehr, Kenton J.; Holmes Jr., David R.
June 2004
Mayo Clinic Proceedings;Jun2004, Vol. 79 Issue 6, p769
Academic Journal
• Objectives: To determine the clinical and angiographic characteristics of patients who underwent coronary artery bypass graft (CABG) surgery before the availability of drug-eluting stents (DES) and to project the potential impact of percutaneous coronary intervention using DES. • Patients and Methods: We reviewed the coronary angiograms obtained between March 1999 and December 2001 of 192 consecutive patients from Olmsted County, Minnesota, who had undergone isolated CABG surgery for the first time. Three interventional cardiologists categorized the patients into 1 of 4 groups on the basis of technical feasibility of complete revascularization by percutaneous coronary intervention with DES. • Results: The study population consisted primarily of men (78%), with a mean age of 67 years. Of the 192 patients, 58 (30%) had diabetes mellitus, and 124 (65%) had 3-vessel disease. Twelve patients (6%) had lesions suitable for stents that matched the inclusion criteria for DES in recently published trials; 77 (40%) had lesions suitable for stents but had lesion characteristics not included in the initial DES trials. Thirty-two patients (17%) had target lesions considered technically difficult, but feasible, for stent placement. Seventy-one patients (37%) had lesions unsuitable for percutaneous coronary intervention (75% of these due to chronic occlusions) with the current stent delivery technology. • Conclusion: This population-based analysis suggests that only a small proportion of patients undergoing CABG surgery meets the strict angiographic eligibility criteria for DES on the basis of recent trials. However, up to 46% of current CABG patients may ultimately undergo conversion to DES. The remaining 54% of this patient population may still not be ideal candidates for DES with the current stent delivery technology.


Related Articles

  • CAB Surgery May Be Superior to Stents Long Term. SCHIESZER, JOHN // Renal & Urology News;Feb2011, Vol. 10 Issue 2, p7 

    The article compares the outcome of drug-eluting stents (DES) and coronary artery bypass (CAB) surgery on patients who require coronary revascularization.

  • Drug-eluting stents comparable with CABG in patients with multivessel disease.  // Cardiology Today;Feb2011, Vol. 14 Issue 2, p25 

    The article discusses a study which showed that mortality rates and adverse events for drug-eluting stent is similar with patients who underwent coronary artery bypass graft (CABG) surgery, but with higher revascularization rate.

  • Images in cardiology: Prison break: getting a distal protection device out of jail. Brett, S.; Gunn, J. // Heart;Aug2009, Vol. 95 Issue 16, p3 

    The article offers information on the condition and treatment of a 60 year old man with worsening angina, eight years after successful coronary artery bypass surgery. It mentions the significant use of a buddy wire inserted to make the distal protection device passed through the lesion and the...

  • Avoiding Cardiac Bypass Surgery. Braverman, Eric R. // Life Extension;Feb2006, Vol. 12 Issue 2, p77 

    This article offers tips for healthy heart, with specific reference several ways that can be helpful in avoiding cardiac bypass surgery. The procedure of bypass surgery can be very debilitating. Some of the common side effects of cardiac bypass surgery are depression, memory loss, and large...

  • Serial angiographic follow-up of grafts one year and five years after coronary artery bypass surgery Cho, Kwang Ree; Kim, Jun-Sung; Choi, Jae-Sung; Kim, Ki-Bong // European Journal of Cardio-Thoracic Surgery;Apr2006, Vol. 29 Issue 4, p511 

    Abstract: Objective: We studied retrospectively the patency of grafts after coronary artery bypass grafting (CABG) using serial angiographies performed one year and five years after surgery. Methods: One hundred and nine patients who had available coronary angiographies at both one year and five...

  • Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention. Farooq, Vasim; Brugaletta, Salvatore; Serruys, Patrick W. // Heart;Dec2011, Vol. 97 Issue 23, p1902 

    Risk stratification is an essential part of appropriately informing patients electing to undergo percutaneous coronary intervention (PCI). This process is also an integral part of the SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery)-pioneered heart team approach in determining the...

  • Target lesion revascularisation in patients treated with a sirolimus-eluting or paclitaxel-eluling stent. Maeng, Michael; Jensen, Lisette Okkels; Rasmussen, Klaus; Lassen, Jens Flensted; Krusell, Lars Romer; Thayssen, Per; Thuesen, Leif // Heart;Jun2007, Vol. 93 Issue 6, p694 

    Objective: To identify risk factors for clinical-driven target lesion revascularisation (TLR) in patients treated with sirolimus-eluting (Cypher) or paclitaxel-eluting (Taxus) stents in a real-world scenario. Design: From 1 January 2003 to 18 May 2005, all patients treated with a Cypher or Taxus...

  • Cardiac revascularization--a need for independent decision-makers. John, Lindsay C. H. // Journal of the Royal Society of Medicine;Jan2005, Vol. 98 Issue 1, p1 

    The author reflects on the decisions to be handled by cardiologist on what interventions should be done to patients with coronary artery diseases. She comments that the cardiologists usually decides whether angioplasty or surgery be the best treatment of the disease but their is not enough...

  • Coronary Artery Bypass Surgery - A Mortality Advantage in the Era of Drug-Eluting Stents? MacKenzie, Ross // Journal of Insurance Medicine;2008, Vol. 40 Issue 1, p12 

    The article discusses long-term mortality data related to the treatment of coronary artery bypass disease (CAD). Topics include coronary artery bypass graft surgery (CABG), percutaneous coronary intervention (PCI), and drug-eluting stents. Also discussed is skepticism related to the expansion of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics